1. Home
  2. PMTS vs TNGX Comparison

PMTS vs TNGX Comparison

Compare PMTS & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CPI Card Group Inc.

PMTS

CPI Card Group Inc.

N/A

Current Price

$24.63

Market Cap

280.3M

Sector

Finance

ML Signal

N/A

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

N/A

Current Price

$24.40

Market Cap

4.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PMTS
TNGX
Founded
2007
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
280.3M
4.1B
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
PMTS
TNGX
Price
$24.63
$24.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
12
Target Price
$32.50
★ $45.18
AVG Volume (30 Days)
227.7K
★ 2.5M
Earning Date
11-03-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 26.89
EPS
★ 0.34
N/A
Revenue
★ $312,189,000.00
$62,384,000.00
Revenue This Year
$11.19
N/A
Revenue Next Year
$8.16
N/A
P/E Ratio
$72.88
★ N/A
Revenue Growth
12.27
★ 48.29
52 Week Low
$10.81
$6.69
52 Week High
$31.25
$34.39

Technical Indicators

Market Signals
Indicator
PMTS
TNGX
Relative Strength Index (RSI) 44.21 55.12
Support Level $21.90 $19.74
Resistance Level $29.57 $26.05
Average True Range (ATR) 0.83 1.53
MACD -0.07 0.29
Stochastic Oscillator 76.00 85.77

Price Performance

Historical Comparison
PMTS
TNGX

About PMTS CPI Card Group Inc.

CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit segment, which principally produce secure debit and credit cards and provide card services for U.S. card-issuing financial institutions, including personalization, instant issuance and other payment solutions such as digital push provisioning for mobile wallets; Prepaid Debit, which provides secure packaging solutions, Prepaid Debit Cards, and other integrated prepaid card services to prepaid program managers in the U.S.; and other: principally corporate expenses. The firm generates key revenue from Debit and Credit segment.

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Share on Social Networks: